Grand Pharmaceutical Group Limited (0512.HK)
Makes and sells medicines, medical devices, and health products across multiple therapeutic areas.
5.15+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-38.7%
The outlook
Grand Pharmaceutical (0512.HK) trades at 5.15, sitting well below both its 50- and 200-day averages and near the lower end of its 52-week range. Analysts unanimously rate it Strong Buy with an average price target implying roughly 131% upside from current levels. The stock shows a neutral overall score, reflecting tension between bullish analyst sentiment and weak recent price momentum.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 3 analysts
Price trendBelow its 50- & 200-day averages
52-week range12% of the way from its 52-week low to high
Price targetAvg target +131% vs current price
Analyst price target
~12-month · 3 analysts11.90average target+131.1% vs now
Now 5.15
Low 11.70High 12.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$18.03B
52-wk high
9.88
52-wk low
4.53
50-day avg
5.15
200-day avg
6.98
Trailing P/E
14.7